Skip to Content
Merck
CN

341276

Anti-Factor H Goat pAb

liquid, Calbiochem®

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.43
UNSPSC Code:
12352203
Clone:
polyclonal
Species reactivity:
human
Application:
Citations:
18

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Anti-Factor H Goat pAb, liquid, Calbiochem®

biological source

goat

antibody form

serum

antibody product type

primary antibodies

clone

polyclonal

form

liquid

contains

≤0.1% sodium azide as preservative

species reactivity

human

manufacturer/tradename

Calbiochem®

availability

not available in Canada

storage condition

OK to freeze
avoid repeated freeze/thaw cycles

dilution

(Radial Immunodiffusion
Ouchterlony (undiluted))

isotype

IgG

shipped in

ambient

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... CFH(3075)

Other Notes

This antibody has also been reported to work for radial immunodiffusion. Variables associated with assay conditions will dictate the proper working dilution.

Packaging

Please refer to vial label for lot-specific concentration.

Physical form

Undiluted serum.

Preparation Note

Following initial thaw, aliquot and freeze (-20°C).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Application

Radial Immunodiffusion (see comments)

Ouchterlony (≥ undiluted)

Disclaimer

Toxicity: Standard Handling (A)

General description

Anti-Factor H, goat polyclonal, recognizes Factor H in human. It is validated for Radial Immunodiffusion and Ouchterlony.
Goat polyclonal antibody supplied as undiluted serum. Recognizes Factor H.
Recognizes Factor H.

Immunogen

Human
purified, human factor H

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk

WGK 1

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Martin Ihnatko et al.
Frontiers in medicine, 8, 789972-789972 (2022-01-22)
COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) is a rare complication of adenoviral vector (ChAdOx1 nCoV-19) vaccine administration. It is presented as thrombocytopenia and thrombotic manifestations in various sites, especially in cerebral veins. Pulmonary emboli have been reported rarely. We present a
Jingyi Li et al.
Frontiers in immunology, 15, 1368322-1368322 (2024-04-01)
Activation of complement through the alternative pathway (AP) has a key role in the pathogenesis of IgA nephropathy (IgAN). We previously showed, by intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), C57BL/6 mice develop mild kidney damage in association
Federica Bianchi et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(11), 12099-12111 (2019-08-24)
The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the Neisseria meningitidis factor
Larisa Chernyaeva et al.
EMBO reports, 24(7), e56467-e56467 (2023-05-08)
The APOE4 variant of apolipoprotein E (apoE) is the most prevalent genetic risk allele associated with late-onset Alzheimer's disease (AD). ApoE interacts with complement regulator factor H (FH), but the role of this interaction in AD pathogenesis is unknown. Here
Daniele Veggi et al.
PLoS pathogens, 16(10), e1008882-e1008882 (2020-10-03)
Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB are now available (i.e. 4CMenB and MenB-fHbp).
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service